KSK19 – Novel histamine H3 receptor ligand reduces body weight in diet induced obese mice-Reference-Cited by-同舟云学术

KSK19 – Novel histamine H3 receptor ligand reduces body weight in diet induced obese mice

Published:2019-10 Issue: Volume:168 Page:193-203
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Kotańska Magdalena,Mika Kamil,Reguła Karolina,Szczepańska Katarzyna,Szafarz Małgorzata^ORCID,Bednarski Marek,Olejarz-Maciej Agnieszka,Nowak Katarzyna,Latacz Gniewomir,Mogilski Szczepan,Kuder Kamil J.,Kieć-Kononowicz Katarzyna,Sapa Jacek

Funder

Faculty of Pharmacy Jagiellonian University Medical College

National Science Center

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference33 articles.

1. The histamine H3 receptor and eating behavior;Passani;J. Pharmacol. Exp. Therap.,2011

2. Leczenie farmakologiczne otyłości – przeszłość, teraźniejszość, przyszłość;Białkowska;Post Nauk. Med.,2000

3. Recent advances In molecular pharmacology of histamine systems: physiology and pharmacology of histamine H3 receptor: roles in feeding regulation and therapeutic potential for metabolic disorders;Tokita;J. Pharmacol. Sci.,2006

4. Histamine receptor subtypes: a century of rational drug design;Walter;Front. Bio. Sci.,2012

5. Histamine H3 receptor as a drug discovery target;Berlin;J. Med. Chem.,2011

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histaminergic regulation of food intake;Frontiers in Endocrinology;2023-06-27

2. Effects of Adjunctive Betahistine Therapy on Lipid Metabolism in Patients with Chronic Schizophrenia: A Randomized Double-Blind Placebo-Controlled Study;Neuropsychiatric Disease and Treatment;2023-02

3. Preliminary Evidence of the Potent and Selective Adenosine A2B Receptor Antagonist PSB-603 in Reducing Obesity and Some of Its Associated Metabolic Disorders in Mice;International Journal of Molecular Sciences;2022-11-03

4. Novel dermal nanobilosomes with promising browning effect of adipose tissue for management of obesity;Journal of Drug Delivery Science and Technology;2022-08

5. KSK-74: Dual Histamine H3 and Sigma-2 Receptor Ligand with Anti-Obesity Potential;International Journal of Molecular Sciences;2022-06-24